AP
TPST icon

Appleton Partners’s Tempest Therapeutics TPST Stock Holding History

Appleton Partners’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5
Closed -$144K – 171
2013
Q3 		$144K Buy
+5
New +$177K 0.04% 165

Other funds holding TPST

DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Appleton Partners's TPST Position: Q4 2013 in Review

Appleton Partners sold out of Tempest Therapeutics (TPST) in Q4 2013, closing a stake of 5 shares — an estimated $144K sold.

Appleton Partners first reported a position in TPST in Q3 2013 and held it in 1 quarter. The position peaked at $144K in Q3 2013. 36 funds tracked by Wall St. Rank hold TPST as of Q4 2013.

  • Appleton Partners reported no remaining Tempest Therapeutics position as of Q4 2013 after selling out during the quarter.
  • Appleton Partners sold 5 Tempest Therapeutics shares in Q4 2013, an estimated $144K.
  • Appleton Partners first reported a position in Tempest Therapeutics in Q3 2013 and held it in 1 quarter.
  • Appleton Partners's Tempest Therapeutics position peaked at $144K in Q3 2013.
  • 36 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2013.

Based on Appleton Partners's 13F filing for Q4 2013, filed 13 Feb 2014.